Impact of QTc prolongation on the occurrence of adverse events in HCM patients.

<p>Sensitivity, specificity, PPV (positive predictive value), NPV (negative predictive value) and OR (odds ratio; adjusted for age and sex) with 95%-CI (confidence intervals) are given in the table below. AE = adverse events (syncope, presyncope, VT).</p

Influence of disease related factors and medication on the orthostatic test result in 69 HCM patients older than or equal to 40 years.

<p>Values are given as total number of patients (n) or as mean ± SD.</p><p>Influence of disease related factors and medication on the orthostatic test result in 69 HCM patients older than or equal to 40 years.</p

Impact of orthostatic test on the occurrence of adverse events in HCM patients for all patients (A) and for the subgroup of patients > 40 yrs (B).

<p>Sensitivity, specificity, PPV (positive predictive value), NPV (negative predictive value) and OR (odds ratio; adjusted for age and sex) with 95%-CI (confidence intervals) are given in the table below. AE = adverse events (syncope, presyncope, VT).</p

Influence of disease related factors and medication on the QTc interval in 100 HCM patients.

<p>Values are given as total number of patients (n) or as mean ± SD.</p><p>Influence of disease related factors and medication on the QTc interval in 100 HCM patients.</p

Relationship between orthostatic test result and QTc prolongation.

<p>The percentages of patients with a positive and negative orthostatic test result are given for the group with and without QTc prolongation.</p